BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17916052)

  • 21. Beyond profiling: using ADMET models to guide decisions.
    Segall M; Champness E; Obrezanova O; Leeding C
    Chem Biodivers; 2009 Nov; 6(11):2144-51. PubMed ID: 19937845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of in silico drug-likeness predictions in pharmaceutical research.
    Tian S; Wang J; Li Y; Li D; Xu L; Hou T
    Adv Drug Deliv Rev; 2015 Jun; 86():2-10. PubMed ID: 25666163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational Biology and Chemistry in MTi: Emphasis on the Prediction of Some ADMET Properties.
    Miteva MA; Villoutreix BO
    Mol Inform; 2017 Oct; 36(10):. PubMed ID: 28221002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computer-aided Drug Design and Drug Pharmacokinetic Prediction: A Mini-review.
    Tabeshpour J; Sahebkar A; Zirak MR; Zeinali M; Hashemzaei M; Rakhshani S; Rakhshani S
    Curr Pharm Des; 2018; 24(26):3014-3019. PubMed ID: 30179125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-ADME relationship: still a long way to go?
    Hou T; Wang J
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):759-70. PubMed ID: 18611116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward in silico structure-based ADMET prediction in drug discovery.
    Moroy G; Martiny VY; Vayer P; Villoutreix BO; Miteva MA
    Drug Discov Today; 2012 Jan; 17(1-2):44-55. PubMed ID: 22056716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico ADME-Tox modeling: progress and prospects.
    Alqahtani S
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational toxicology approaches at the US Food and Drug Administration.
    Yang C; Valerio LG; Arvidson KB
    Altern Lab Anim; 2009 Nov; 37(5):523-31. PubMed ID: 20017581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive ADMET studies, the challenges and the opportunities.
    Davis AM; Riley RJ
    Curr Opin Chem Biol; 2004 Aug; 8(4):378-86. PubMed ID: 15288247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico quantitative structure toxicity relationship of chemical compounds: some case studies.
    Deeb O; Goodarzi M
    Curr Drug Saf; 2012 Sep; 7(4):289-97. PubMed ID: 23062241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico toxicology in drug discovery - concepts based on three-dimensional models.
    Vedani A; Smiesko M
    Altern Lab Anim; 2009 Nov; 37(5):477-96. PubMed ID: 20017578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J; Skolnik S
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico human and rat Vss quantitative structure-activity relationship models.
    Gleeson MP; Waters NJ; Paine SW; Davis AM
    J Med Chem; 2006 Mar; 49(6):1953-63. PubMed ID: 16539383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and ADMET: Where are we now.
    Smith DA
    Curr Top Med Chem; 2011; 11(4):467-81. PubMed ID: 21320070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADMET modeling approaches in drug discovery.
    Ferreira LLG; Andricopulo AD
    Drug Discov Today; 2019 May; 24(5):1157-1165. PubMed ID: 30890362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational approaches to predict drug metabolism.
    Czodrowski P; Kriegl JM; Scheuerer S; Fox T
    Expert Opin Drug Metab Toxicol; 2009 Jan; 5(1):15-27. PubMed ID: 19236226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent developments of in silico predictions of intestinal absorption and oral bioavailability.
    Hou T; Li Y; Zhang W; Wang J
    Comb Chem High Throughput Screen; 2009 Jun; 12(5):497-506. PubMed ID: 19519329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early prediction of drug metabolism and toxicity: systems biology approach and modeling.
    Bugrim A; Nikolskaya T; Nikolsky Y
    Drug Discov Today; 2004 Feb; 9(3):127-35. PubMed ID: 14960390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-principle, structure-based prediction of hepatic metabolic clearance values in human.
    Li H; Sun J; Sui X; Liu J; Yan Z; Liu X; Sun Y; He Z
    Eur J Med Chem; 2009 Apr; 44(4):1600-6. PubMed ID: 18768239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties.
    Xiong G; Wu Z; Yi J; Fu L; Yang Z; Hsieh C; Yin M; Zeng X; Wu C; Lu A; Chen X; Hou T; Cao D
    Nucleic Acids Res; 2021 Jul; 49(W1):W5-W14. PubMed ID: 33893803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.